Author

Daniel P. Smith

BenevolentAI (United Kingdom)ORCID 0000-0002-2479-2044Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1

Frequent Co-Authors

Allan Christian ShawiD· 1 shared Amy F. A. KeerieiD· 1 shared Anne Phelan· 1 shared Chloe F. AlleniD· 1 shared David W. SheppardiD· 1 shared Heledd Brown-WrightiD· 1 shared Laura FerraiuoloiD· 1 shared Matthew J. StopfordiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Allan Christian ShawORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeurosciencebioRxivPreprintMar 6, 2025

Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALS

Monika A. Myszczynska, Matthew J. Stopford, Nóra M. Márkus…·Laura Ferraiuolo

This paper uses AI to identify gefitinib as a potential ALS treatment, showing it protects motor neurons and reduces TDP-43 fragments in vitro and in vivo.

2 citations

humanmouse

𝕏 PostBluesky